BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33863237)

  • 1. Antimicrobial and resource utilization with T2 magnetic resonance for rapid diagnosis of bloodstream infections: systematic review with meta-analysis of controlled studies.
    Giannella M; Pankey GA; Pascale R; Miller VM; Miller LE; Seitz T
    Expert Rev Med Devices; 2021 May; 18(5):473-482. PubMed ID: 33863237
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19.
    Seitz T; Holbik J; Hind J; Gibas G; Karolyi M; Pawelka E; Traugott M; Wenisch C; Zoufaly A
    Microbiol Spectr; 2022 Jun; 10(3):e0014022. PubMed ID: 35695564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience.
    Quirino A; Scaglione V; Marascio N; Mazzitelli M; Garofalo E; Divenuto F; Serapide F; Bruni A; Lionello R; Pavia G; Costa C; Giancotti A; Peronace C; Longhini F; Russo A; Liberto MC; Matera G; Torti C; Trecarichi EM
    BMC Infect Dis; 2022 Feb; 22(1):113. PubMed ID: 35105333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of MALDI-TOF-MS-based identification directly from positive blood cultures on patient management: a controlled clinical trial.
    Osthoff M; Gürtler N; Bassetti S; Balestra G; Marsch S; Pargger H; Weisser M; Egli A
    Clin Microbiol Infect; 2017 Feb; 23(2):78-85. PubMed ID: 27569710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unit.
    Gill CM; Kenney RM; Hencken L; Mlynarek ME; Alangaden GJ; Samuel LP; Davis SL
    Diagn Microbiol Infect Dis; 2019 Oct; 95(2):162-165. PubMed ID: 31248660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial.
    Leone M; Bechis C; Baumstarck K; Lefrant JY; Albanèse J; Jaber S; Lepape A; Constantin JM; Papazian L; Bruder N; Allaouchiche B; Bézulier K; Antonini F; Textoris J; Martin C;
    Intensive Care Med; 2014 Oct; 40(10):1399-408. PubMed ID: 25091790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial.
    Mylonakis E; Zacharioudakis IM; Clancy CJ; Nguyen MH; Pappas PG
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-depth analysis of T2Bacteria positive results in patients with concurrent negative blood culture: a case series.
    Kalligeros M; Zacharioudakis IM; Tansarli GS; Tori K; Shehadeh F; Mylonakis E
    BMC Infect Dis; 2020 May; 20(1):326. PubMed ID: 32380973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
    Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
    Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock.
    Gomes Silva BN; Andriolo RB; Atallah AN; Salomão R
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007934. PubMed ID: 21154391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-flow nasal cannulae for respiratory support in adult intensive care patients.
    Corley A; Rickard CM; Aitken LM; Johnston A; Barnett A; Fraser JF; Lewis SR; Smith AF
    Cochrane Database Syst Rev; 2017 May; 5(5):CD010172. PubMed ID: 28555461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis.
    Paul M; Dickstein Y; Raz-Pasteur A
    Clin Microbiol Infect; 2016 Dec; 22(12):960-967. PubMed ID: 27283148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective Rapid Diagnosis of Bacterial and Fungal Bloodstream Infections by T2 Magnetic Resonance Technology in the Pediatric Population.
    Lucignano B; Cento V; Agosta M; Ambrogi F; Albitar-Nehme S; Mancinelli L; Mattana G; Onori M; Galaverna F; Di Chiara L; Fragasso T; Bianchi R; Tortora F; Auriti C; Dotta A; Cecchetti C; Perdichizzi S; Raponi M; Onetti Muda A; Nerini Molteni S; Villani A; Locatelli F; Perno CF; Bernaschi P
    J Clin Microbiol; 2022 Oct; 60(10):e0029222. PubMed ID: 36069557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.
    Muñoz P; Vena A; Machado M; Gioia F; Martínez-Jiménez MC; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Fernández-Ruiz M; Merino P; González-Romo F; Frías I; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
    J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv6-iv12. PubMed ID: 29608751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood.
    Neely LA; Audeh M; Phung NA; Min M; Suchocki A; Plourde D; Blanco M; Demas V; Skewis LR; Anagnostou T; Coleman JJ; Wellman P; Mylonakis E; Lowery TJ
    Sci Transl Med; 2013 Apr; 5(182):182ra54. PubMed ID: 23616121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Analysis of Implementing Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Plus Real-Time Antimicrobial Stewardship Intervention for Bloodstream Infections.
    Patel TS; Kaakeh R; Nagel JL; Newton DW; Stevenson JG
    J Clin Microbiol; 2017 Jan; 55(1):60-67. PubMed ID: 27795335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T2 magnetic resonance for the diagnosis of bloodstream infections: charting a path forward.
    Clancy CJ; Nguyen MH
    J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv2-iv5. PubMed ID: 29608754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications.
    Zacharioudakis IM; Zervou FN; Mylonakis E
    J Fungi (Basel); 2018 Apr; 4(2):. PubMed ID: 29617284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.